| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |